TAAT® Products to Expand in Austin, TX With GAMA Partnership
TAAT® Products to Expand in Austin, TX With GAMA Partnership
Picture 1
圖1
LAS VEGAS and VANCOUVER, British Columbia, Oct. 18, 2022 (GLOBE NEWSWIRE) -- TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the "Company" or "TAAT®") is pleased to announce that starting in November 2022 TAAT® Original, Smooth, and Menthol are to be carried by the Greater Austin Merchants Cooperative Association ("GAMA"). GAMA services over 600 member stores in central Texas, primarily in the Austin area (population 965,000), in addition to more than 1,200 other retail locations supported and distributed to by the association. The Company continues to build out the presence of TAAT® throughout the state of Texas, now with three leading convenience retailers. Wholesale buying cooperatives such as GAMA provide the platform to penetrate hundreds of independent retailers, in a manner that is similar to standard chain account sales. TAAT® merchandisers will work hand-in-hand with GAMA to execute at retail stores operated by GAMA accounts in Austin for the purpose of educating retailers, staff, and adult smokers about the unique value proposition of TAAT®. The Company formed its relationship with GAMA through B&B Beyond (announced in a September 13, 2022 press release), who is representing TAAT® among a network of convenience industry contacts in the United States.
不列顛哥倫比亞省拉斯維加斯和温哥華，2022年10月18日(環球通訊社)塔特®全球替代方案公司。(CSE：TAT)(OTCQX：TOBAF)(法蘭克福：2TP)(“公司”或“TAT®”)很高興地宣佈，從2022年11月開始，塔特®原創, 平滑，以及薄荷醇將由大奧斯汀商人合作協會(GAMA)負責。GAMA為德克薩斯州中部的600多家會員商店提供服務，主要是在奧斯汀地區(人口965,000人)，此外還有該協會支持和分銷的1200多個其他零售點。該公司繼續擴大塔特®在得克薩斯州的業務，目前擁有三家領先的便利零售商。GAMA等批發購買合作社提供了滲透數百家獨立零售商的平臺，其方式類似於標準的連鎖賬户銷售。塔特®銷售員將與GAMA攜手在奧斯汀由GAMA賬户運營的零售店執行，目的是教育零售商、員工和成年吸煙者瞭解塔特®的獨特價值主張。該公司通過B&B Beyond(在2022年9月13日的新聞稿中宣佈)與GAMA建立了關係，後者是Taat®在美國便利業聯繫人網絡中的代表。
TAAT® Chief Executive Officer Michael Saxon commented, "With our GAMA partnership, we will have the scale to fully launch TAAT® in the Austin, TX market. Groups such as GAMA diligently identify opportunities for their members to improve store profitability, which will be a major selling point of TAAT® as a product with significantly higher profit margins for retailers compared to what they earn selling tobacco cigarettes. Texas is an important market for the Company, and we look forward to working with GAMA as part of our expansion plans."
塔特®首席執行官邁克爾·薩克森評論説：“有了我們的夥伴關係，我們將有足夠的規模在德克薩斯州奧斯汀市場全面推出塔特®。像塔特®這樣的集團努力為其成員尋找提高商店盈利能力的機會，這將是塔特®的一個主要賣點，與他們銷售香煙相比，零售商的利潤率要高得多。德克薩斯州是該公司的一個重要市場，我們期待着與GAMA合作，作為我們擴張計劃的一部分。”
GAMA Vice President Ernie Limon stated, "We are all about providing innovative products to our member retailers, alongside legacy mainstays such as tobacco, soda, and confection. Although certain segments within convenience virtually never change, category-creating products such as TAAT® provide a win for adult smokers who can benefit from a low-cost and nicotine-free option, as well as a win for retailers who make significantly more on each sale of this non-tobacco product. This value proposition is very straightforward, and I believe will result in a strong conversion rate for capturing market share among our accounts in the Austin area. GAMA is excited to be introducing TAAT® as an innovative product within its network, in a market where TAAT® is already an established brand name."
GAMA副總裁總裁厄尼·利蒙表示：“我們致力於向我們的會員零售商提供創新產品，以及煙草、汽水和糖果等傳統支柱產品。儘管便利性中的某些細分市場幾乎永遠不會改變，但品類創造產品，如Tat®，為成年吸煙者提供了一種勝利，他們可以從低成本和不含尼古丁的選擇中受益，也為零售商提供了勝利，他們從這種非煙草產品的每一次銷售中賺取了顯著更多的收入。這一價值主張非常直截了當，我相信這將導致我們在奧斯汀地區的客户中獲得市場份額的強勁轉換率。伽馬很高興能在其網絡中推出塔特®作為其網絡中的一種創新產品，在一個塔特®已經是一個知名品牌的市場上。“
Founded in 1999, GAMA's members represent approximately 35% of the convenience market in the Austin area, with over USD $1 billion in combined revenues annually. GAMA owns and operates its own warehouse and distribution centre in Austin, and is in the process of adding a 300,000 square foot warehouse in Georgetown, TX, which will also act as a "cash-and-carry" point of sale for wholesale purchases. In addition to a standard range of convenience category wares, GAMA stocks a full selection of tobacco products to include major brands of tobacco cigarettes. More information about GAMA can be found on its website at the following link:
GAMA成立於1999年，其成員約佔奧斯汀地區便利市場的35%，年總收入超過10億美元。GAMA在奧斯汀擁有並運營自己的倉庫和配送中心，目前正在德克薩斯州喬治敦增加一個30萬平方英尺的倉庫，該倉庫還將作為批發採購的“現金自運”銷售點。除了一系列標準的便利類商品外，GAMA還儲備了包括主要品牌煙草在內的全套煙草產品。有關GAMA的更多信息，請訪問GAMA網站的以下鏈接：
GAMA members represent over 600 stores in central Texas, mainly in the Austin area. The map above shows the locations of its members' stores, which collectively account for approximately 35% of the Austin-area convenience market. TAAT® and GAMA will be working together to strategically commercialize the Company's novel alternative to tobacco cigarettes throughout the convenience channel in the Austin area, where TAAT® is presently sold in independent stores as well as chain retailers.
GAMA會員代表着德克薩斯州中部的600多家商店，主要是在奧斯汀地區。上面的地圖顯示了其會員商店的位置，這些商店加起來約佔奧斯汀地區便利店市場的35%。塔特®公司和GAMA公司將合作，在奧斯汀地區的便利渠道對該公司替代煙草捲煙的新型產品進行戰略性商業化。目前，該地區的獨立商店和連鎖零售商都在銷售塔特®公司的產品。
A photo accompanying this announcement is available at
這一公告附帶的照片可在以下網址查閲
Readers using news aggregation services may be unable to view the media above. Please access SEDAR or the Investor Relations section of the Company's website for a version of this press release containing all published media.
使用新聞聚合服務的讀者可能無法查看上面的媒體。請訪問SEDAR或投資者關係有關本新聞稿的版本，請訪問公司網站的部分，其中包含所有已發佈的媒體。
On behalf of the Board of Directors of the Company,
我謹代表公司董事會：
TAAT® GLOBAL ALTERNATIVES INC.
塔特®全球替代方案公司。
"Michael Saxon"
《邁克爾·薩克森》
Michael Saxon, CEO and Director
董事首席執行官邁克爾·薩克森
For further information, please contact:
如需更多信息，請聯繫：
TAAT® Investor Relations
1-833-TAAT-USA (1-833-822-8872)
investor@taatglobal.com
塔特®投資者關係
1-833-TAT-USA(1-833-822-8872)
電子郵箱：Investors@taatlobal.com
THE CANADIAN SECURITIES EXCHANGE ("CSE") HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE'S REGULATION SERVICES PROVIDER.
加拿大證券交易所(“CSE”)沒有對本新聞稿的準確性或充分性進行審查，也不承擔責任，CSE的監管服務提供商也沒有或不承擔責任。
About TAAT® Global Alternatives Inc.
關於Taat®全球替代方案公司
TAAT® develops, manufactures, and distributes alternative products in categories such as tobacco, hemp, kratom, and other emerging CPG segments. Its flagship product is a nicotine-free/tobacco-free combustible with a patent-pending base material formulation, sold in several thousand U.S. stores. With over CAD $80 million in overall gross revenue annually, TAAT®'s facilities include an operations centre in Nevada, as well as a distribution centre and multiple convenience stores in Ohio.
Taat®開發、製造和分銷煙草、大麻、KrATOM和其他新興CPG細分市場等類別的替代產品。其旗艦產品是一種無尼古丁/無煙草可燃材料，其基材配方正在申請專利，在美國數千家門店銷售。®的設施包括位於內華達州的運營中心，以及位於俄亥俄州的配送中心和多家便利店，年總收入超過8000萬加元。
For more information, please visit
欲瞭解更多信息，請訪問
Forward-Looking Statements
前瞻性陳述
This news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information and information can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur, or be achieved. Forward-looking information in this news release includes statements regarding the anticipated performance of TAAT® in the tobacco industry, in addition to the following: Successful commencement of GAMA carrying TAAT® products beginning in November 2022, potential placements and sales of TAAT® made through GAMA. The forward-looking information reflects management's current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed timeframes or at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the tobacco markets; (iii) changes to the regulatory landscape applicable to the Company's business; and (iv) other factors beyond the control of the Company. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company's management to predict all risk factors, nor can the Company assess the impact of all factors on Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. The forward-looking information included in this news release are made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law.
本新聞稿包含適用於加拿大證券法的“前瞻性信息”。前瞻性信息和信息常常但不總是可以通過使用諸如“計劃”、“預期”或“不預期”、“預期”、“估計”、“打算”、“預期”或“不預期”或“相信”等詞語或這些詞語和短語的變體來識別，或陳述某些行動、事件或結果“可能”、“可能”、“將”、“可能”或“將”被採取、發生或實現。本新聞稿中的前瞻性信息包括有關TaT®在煙草行業的預期表現的陳述，此外還包括：從2022年11月開始成功開始攜帶TaT®產品的GAMA，通過GAMA進行的TAT®的潛在配售和銷售。前瞻性信息反映了管理層基於現有信息的當前預期，可能會受到一些風險和不確定因素的影響，這些風險和不確定因素可能導致結果與前瞻性信息中討論的結果大不相同。儘管本公司認為編制前瞻性信息時使用的假設和因素是合理的，但不應過度依賴這些信息，也不能保證此類事件將在披露的時間框架內發生或根本不會發生。可能導致實際結果或事件與當前預期大不相同的因素包括：(I)不利的市場狀況；(Ii)煙草市場增長和規模的變化；(Iii)適用於公司業務的監管環境的變化；以及(Iv)公司無法控制的其他因素。該公司在一個快速發展的環境中運營。新的風險因素時有出現, 公司管理層不可能預測所有風險因素，也無法評估所有因素對公司業務的影響，或任何因素或因素組合可能導致實際結果與任何前瞻性信息中包含的結果不同的程度。本新聞稿中包含的前瞻性信息是截至本新聞稿發佈之日的信息，除適用法律要求外，公司明確表示不會因新信息、未來事件或其他原因而更新或修改任何前瞻性信息，也不承擔任何義務。
The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company's products will vary from person to person. No claims or guarantees can be made as to the effects of the Company's products on an individual's health and well-being. The Company's products are not intended to diagnose, treat, cure, or prevent any disease.
本新聞稿中的聲明尚未經過加拿大衞生部或美國食品和藥物管理局的評估。由於每個人都不同，服用該公司產品的好處(如果有的話)將因人而異。不能就公司產品對個人健康和福祉的影響提出任何索賠或保證。該公司的產品並非用於診斷、治療、治癒或預防任何疾病。
This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by the Company with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with the Company is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees.
本新聞稿可能包含第三方實體(或其各自產品的商標名稱)的商標名稱，通常指的是(I)本新聞稿中提及的公司與此類第三方實體之間的關係和/或(Ii)本新聞稿中提到的與公司有關係的客户/供應商/服務提供商。這些商標的所有權利由其各自的所有者或被許可人保留。
Statement Regarding Third-Party Investor Relations Firms
關於第三方投資者關係公司的聲明
Disclosures relating to investor relations firms retained by TAAT® Global Alternatives Inc. can be found under the Company's profile on
有關塔特®全球替代方案公司保留的投資者關係公司的披露，可在該公司的簡介中找到，網址為
譯文內容由第三人軟體翻譯。